Activation of the unfolded protein response downregulates cardiac ion channels in human induced pluripotent stem cell-derived cardiomyocytes
Heart failure is characterized by electrical remodeling that contributes to arrhythmic risk. The unfolded protein response (UPR) is active in heart failure and can decrease protein levels by increasing mRNA decay, accelerating protein degradation, and inhibiting protein translation. Therefore, we in...
Gespeichert in:
Veröffentlicht in: | Journal of molecular and cellular cardiology 2018-04, Vol.117, p.62-71 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 71 |
---|---|
container_issue | |
container_start_page | 62 |
container_title | Journal of molecular and cellular cardiology |
container_volume | 117 |
creator | Liu, Man Shi, Guangbin Zhou, Anyu Rupert, Cassady E. Coulombe, Kareen L.K. Dudley, Samuel C. |
description | Heart failure is characterized by electrical remodeling that contributes to arrhythmic risk. The unfolded protein response (UPR) is active in heart failure and can decrease protein levels by increasing mRNA decay, accelerating protein degradation, and inhibiting protein translation.
Therefore, we investigated whether the UPR downregulated cardiac ion channels that may contribute to arrhythmogenic electrical remodeling.
Human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) were used to study cardiac ion channels. Action potentials (APs) and ion channel currents were measured by patch clamp recording. The mRNA and protein levels of channels and the UPR effectors were determined by quantitative RT-PCR and Western blotting. Tunicamycin (TM, 50 ng/mL and 5 μg/mL), GSK2606414 (GSK, 300 nmol/L), and 4μ8C (5 μmol/L) were utilized to activate the UPR, inhibit protein kinase-like ER kinase (PERK) and inositol-requiring protein-1 (IRE1), respectively.
TM-induced activation of the UPR caused significant prolongation of the AP duration (APD) and a reduction of the maximum upstroke velocity (dV/dtmax) of the AP phase 0 in both acute (20–24 h) and chronic treatment (6 days). These changes were explained by reductions in the sodium, L-type calcium, the transient outward and rapidly/slowly activating delayed rectifier potassium currents. Nav1.5, Cav1.2, Kv4.3, and KvLQT1 channels showed concomitant reductions in mRNA and protein levels under activated UPR. Inhibition of PERK or IRE1 shortened the APD and reinstated dV/dtmax. The PERK branch regulated Nav1.5, Kv4.3, hERG, and KvLQT1. The IRE1 branch regulated Nav1.5, hERG, KvLQT1, and Cav1.2.
Activated UPR downregulates all major cardiac ion currents and results in electrical remodeling in hiPSC-CMs. Both PERK and IRE1 branches downregulate Nav1.5, hERG, and KvLQT1. The PERK branch specifically downregulates Kv4.3, while the IRE1 branch downregulates Cav1.2. Therefore, the UPR contributed to electrical remodeling, and targeting the UPR might be anti-arrhythmic.
•The unfolded protein response mediates arrhythmic electrical remodeling•Activated unfolded protein response downregulates all major cardiac ion currents•Electrical remodeling results in action potential prolongation•Electrical remodeling can be attenuated by inhibiting the unfolded protein response |
doi_str_mv | 10.1016/j.yjmcc.2018.02.011 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5861016</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0022282818300452</els_id><sourcerecordid>2007987379</sourcerecordid><originalsourceid>FETCH-LOGICAL-c459t-6716cedd00287f5e0e6b53d398ca919d2f7b60363d2f7ef43864e9236587b0b13</originalsourceid><addsrcrecordid>eNp9kcluFDEQhi0EIkPgCZCQj1y68dKLfQApitikSFzgbLnt6oxH3XZjuyead-ChcWdCBBdOVVL99dXyI_SakpoS2r071KfDbEzNCBU1YTWh9AnaUSLbSrSieYp2hDBWMcHEBXqR0oEQIhvOn6MLJpu-EbTfoV9XJrujzi54HEac94BXP4bJgsVLDBmcxxHSEnwCbMOdj3C7TjpDwkZH67TBW6vZa-9hSrjI9-usfUnsajbItEa3FJDPOGWYsYFpqixEdyzVe0aYT8GcCvIlejbqKcGrh3iJfnz6-P36S3Xz7fPX66ubyjStzFXX066gbTlP9GMLBLqh5ZZLYbSk0rKxHzrCO75lMDZcdA1IxrtW9AMZKL9EH87cZR1msKbsFvWkluhmHU8qaKf-rXi3V7fhqFrRba8vgLcPgBh-rpCyml3aDtMewpoUI6SXoue9LFJ-lpoYUoowPo6hRG0wdVD3PqrNR0WYKj6Wrjd_b_jY88e4Inh_FpSnw9FBVMk48OUtLoLJygb33wG_AawBtMo</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2007987379</pqid></control><display><type>article</type><title>Activation of the unfolded protein response downregulates cardiac ion channels in human induced pluripotent stem cell-derived cardiomyocytes</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>Liu, Man ; Shi, Guangbin ; Zhou, Anyu ; Rupert, Cassady E. ; Coulombe, Kareen L.K. ; Dudley, Samuel C.</creator><creatorcontrib>Liu, Man ; Shi, Guangbin ; Zhou, Anyu ; Rupert, Cassady E. ; Coulombe, Kareen L.K. ; Dudley, Samuel C.</creatorcontrib><description>Heart failure is characterized by electrical remodeling that contributes to arrhythmic risk. The unfolded protein response (UPR) is active in heart failure and can decrease protein levels by increasing mRNA decay, accelerating protein degradation, and inhibiting protein translation.
Therefore, we investigated whether the UPR downregulated cardiac ion channels that may contribute to arrhythmogenic electrical remodeling.
Human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) were used to study cardiac ion channels. Action potentials (APs) and ion channel currents were measured by patch clamp recording. The mRNA and protein levels of channels and the UPR effectors were determined by quantitative RT-PCR and Western blotting. Tunicamycin (TM, 50 ng/mL and 5 μg/mL), GSK2606414 (GSK, 300 nmol/L), and 4μ8C (5 μmol/L) were utilized to activate the UPR, inhibit protein kinase-like ER kinase (PERK) and inositol-requiring protein-1 (IRE1), respectively.
TM-induced activation of the UPR caused significant prolongation of the AP duration (APD) and a reduction of the maximum upstroke velocity (dV/dtmax) of the AP phase 0 in both acute (20–24 h) and chronic treatment (6 days). These changes were explained by reductions in the sodium, L-type calcium, the transient outward and rapidly/slowly activating delayed rectifier potassium currents. Nav1.5, Cav1.2, Kv4.3, and KvLQT1 channels showed concomitant reductions in mRNA and protein levels under activated UPR. Inhibition of PERK or IRE1 shortened the APD and reinstated dV/dtmax. The PERK branch regulated Nav1.5, Kv4.3, hERG, and KvLQT1. The IRE1 branch regulated Nav1.5, hERG, KvLQT1, and Cav1.2.
Activated UPR downregulates all major cardiac ion currents and results in electrical remodeling in hiPSC-CMs. Both PERK and IRE1 branches downregulate Nav1.5, hERG, and KvLQT1. The PERK branch specifically downregulates Kv4.3, while the IRE1 branch downregulates Cav1.2. Therefore, the UPR contributed to electrical remodeling, and targeting the UPR might be anti-arrhythmic.
•The unfolded protein response mediates arrhythmic electrical remodeling•Activated unfolded protein response downregulates all major cardiac ion currents•Electrical remodeling results in action potential prolongation•Electrical remodeling can be attenuated by inhibiting the unfolded protein response</description><identifier>ISSN: 0022-2828</identifier><identifier>EISSN: 1095-8584</identifier><identifier>DOI: 10.1016/j.yjmcc.2018.02.011</identifier><identifier>PMID: 29474817</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Action Potentials - drug effects ; Adenine - analogs & derivatives ; Adenine - pharmacology ; Down-Regulation - drug effects ; eIF-2 Kinase - metabolism ; Endoribonucleases - metabolism ; Heart failure ; hiPSC-derived cardiomyocytes ; Humans ; Indoles - pharmacology ; Induced Pluripotent Stem Cells - cytology ; Ion Channel Gating - drug effects ; Ion Channels - metabolism ; IRE1 ; Isoproterenol - pharmacology ; Myocytes, Cardiac - drug effects ; Myocytes, Cardiac - metabolism ; PERK ; Protein-Serine-Threonine Kinases - metabolism ; Tunicamycin - pharmacology ; Unfolded Protein Response - drug effects ; Ventricular Remodeling - drug effects</subject><ispartof>Journal of molecular and cellular cardiology, 2018-04, Vol.117, p.62-71</ispartof><rights>2018 Elsevier Ltd</rights><rights>Copyright © 2018 Elsevier Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c459t-6716cedd00287f5e0e6b53d398ca919d2f7b60363d2f7ef43864e9236587b0b13</citedby><cites>FETCH-LOGICAL-c459t-6716cedd00287f5e0e6b53d398ca919d2f7b60363d2f7ef43864e9236587b0b13</cites><orcidid>0000-0001-5843-5961</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0022282818300452$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>230,314,776,780,881,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29474817$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Liu, Man</creatorcontrib><creatorcontrib>Shi, Guangbin</creatorcontrib><creatorcontrib>Zhou, Anyu</creatorcontrib><creatorcontrib>Rupert, Cassady E.</creatorcontrib><creatorcontrib>Coulombe, Kareen L.K.</creatorcontrib><creatorcontrib>Dudley, Samuel C.</creatorcontrib><title>Activation of the unfolded protein response downregulates cardiac ion channels in human induced pluripotent stem cell-derived cardiomyocytes</title><title>Journal of molecular and cellular cardiology</title><addtitle>J Mol Cell Cardiol</addtitle><description>Heart failure is characterized by electrical remodeling that contributes to arrhythmic risk. The unfolded protein response (UPR) is active in heart failure and can decrease protein levels by increasing mRNA decay, accelerating protein degradation, and inhibiting protein translation.
Therefore, we investigated whether the UPR downregulated cardiac ion channels that may contribute to arrhythmogenic electrical remodeling.
Human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) were used to study cardiac ion channels. Action potentials (APs) and ion channel currents were measured by patch clamp recording. The mRNA and protein levels of channels and the UPR effectors were determined by quantitative RT-PCR and Western blotting. Tunicamycin (TM, 50 ng/mL and 5 μg/mL), GSK2606414 (GSK, 300 nmol/L), and 4μ8C (5 μmol/L) were utilized to activate the UPR, inhibit protein kinase-like ER kinase (PERK) and inositol-requiring protein-1 (IRE1), respectively.
TM-induced activation of the UPR caused significant prolongation of the AP duration (APD) and a reduction of the maximum upstroke velocity (dV/dtmax) of the AP phase 0 in both acute (20–24 h) and chronic treatment (6 days). These changes were explained by reductions in the sodium, L-type calcium, the transient outward and rapidly/slowly activating delayed rectifier potassium currents. Nav1.5, Cav1.2, Kv4.3, and KvLQT1 channels showed concomitant reductions in mRNA and protein levels under activated UPR. Inhibition of PERK or IRE1 shortened the APD and reinstated dV/dtmax. The PERK branch regulated Nav1.5, Kv4.3, hERG, and KvLQT1. The IRE1 branch regulated Nav1.5, hERG, KvLQT1, and Cav1.2.
Activated UPR downregulates all major cardiac ion currents and results in electrical remodeling in hiPSC-CMs. Both PERK and IRE1 branches downregulate Nav1.5, hERG, and KvLQT1. The PERK branch specifically downregulates Kv4.3, while the IRE1 branch downregulates Cav1.2. Therefore, the UPR contributed to electrical remodeling, and targeting the UPR might be anti-arrhythmic.
•The unfolded protein response mediates arrhythmic electrical remodeling•Activated unfolded protein response downregulates all major cardiac ion currents•Electrical remodeling results in action potential prolongation•Electrical remodeling can be attenuated by inhibiting the unfolded protein response</description><subject>Action Potentials - drug effects</subject><subject>Adenine - analogs & derivatives</subject><subject>Adenine - pharmacology</subject><subject>Down-Regulation - drug effects</subject><subject>eIF-2 Kinase - metabolism</subject><subject>Endoribonucleases - metabolism</subject><subject>Heart failure</subject><subject>hiPSC-derived cardiomyocytes</subject><subject>Humans</subject><subject>Indoles - pharmacology</subject><subject>Induced Pluripotent Stem Cells - cytology</subject><subject>Ion Channel Gating - drug effects</subject><subject>Ion Channels - metabolism</subject><subject>IRE1</subject><subject>Isoproterenol - pharmacology</subject><subject>Myocytes, Cardiac - drug effects</subject><subject>Myocytes, Cardiac - metabolism</subject><subject>PERK</subject><subject>Protein-Serine-Threonine Kinases - metabolism</subject><subject>Tunicamycin - pharmacology</subject><subject>Unfolded Protein Response - drug effects</subject><subject>Ventricular Remodeling - drug effects</subject><issn>0022-2828</issn><issn>1095-8584</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kcluFDEQhi0EIkPgCZCQj1y68dKLfQApitikSFzgbLnt6oxH3XZjuyead-ChcWdCBBdOVVL99dXyI_SakpoS2r071KfDbEzNCBU1YTWh9AnaUSLbSrSieYp2hDBWMcHEBXqR0oEQIhvOn6MLJpu-EbTfoV9XJrujzi54HEac94BXP4bJgsVLDBmcxxHSEnwCbMOdj3C7TjpDwkZH67TBW6vZa-9hSrjI9-usfUnsajbItEa3FJDPOGWYsYFpqixEdyzVe0aYT8GcCvIlejbqKcGrh3iJfnz6-P36S3Xz7fPX66ubyjStzFXX066gbTlP9GMLBLqh5ZZLYbSk0rKxHzrCO75lMDZcdA1IxrtW9AMZKL9EH87cZR1msKbsFvWkluhmHU8qaKf-rXi3V7fhqFrRba8vgLcPgBh-rpCyml3aDtMewpoUI6SXoue9LFJ-lpoYUoowPo6hRG0wdVD3PqrNR0WYKj6Wrjd_b_jY88e4Inh_FpSnw9FBVMk48OUtLoLJygb33wG_AawBtMo</recordid><startdate>20180401</startdate><enddate>20180401</enddate><creator>Liu, Man</creator><creator>Shi, Guangbin</creator><creator>Zhou, Anyu</creator><creator>Rupert, Cassady E.</creator><creator>Coulombe, Kareen L.K.</creator><creator>Dudley, Samuel C.</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0001-5843-5961</orcidid></search><sort><creationdate>20180401</creationdate><title>Activation of the unfolded protein response downregulates cardiac ion channels in human induced pluripotent stem cell-derived cardiomyocytes</title><author>Liu, Man ; Shi, Guangbin ; Zhou, Anyu ; Rupert, Cassady E. ; Coulombe, Kareen L.K. ; Dudley, Samuel C.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c459t-6716cedd00287f5e0e6b53d398ca919d2f7b60363d2f7ef43864e9236587b0b13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Action Potentials - drug effects</topic><topic>Adenine - analogs & derivatives</topic><topic>Adenine - pharmacology</topic><topic>Down-Regulation - drug effects</topic><topic>eIF-2 Kinase - metabolism</topic><topic>Endoribonucleases - metabolism</topic><topic>Heart failure</topic><topic>hiPSC-derived cardiomyocytes</topic><topic>Humans</topic><topic>Indoles - pharmacology</topic><topic>Induced Pluripotent Stem Cells - cytology</topic><topic>Ion Channel Gating - drug effects</topic><topic>Ion Channels - metabolism</topic><topic>IRE1</topic><topic>Isoproterenol - pharmacology</topic><topic>Myocytes, Cardiac - drug effects</topic><topic>Myocytes, Cardiac - metabolism</topic><topic>PERK</topic><topic>Protein-Serine-Threonine Kinases - metabolism</topic><topic>Tunicamycin - pharmacology</topic><topic>Unfolded Protein Response - drug effects</topic><topic>Ventricular Remodeling - drug effects</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Liu, Man</creatorcontrib><creatorcontrib>Shi, Guangbin</creatorcontrib><creatorcontrib>Zhou, Anyu</creatorcontrib><creatorcontrib>Rupert, Cassady E.</creatorcontrib><creatorcontrib>Coulombe, Kareen L.K.</creatorcontrib><creatorcontrib>Dudley, Samuel C.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of molecular and cellular cardiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Liu, Man</au><au>Shi, Guangbin</au><au>Zhou, Anyu</au><au>Rupert, Cassady E.</au><au>Coulombe, Kareen L.K.</au><au>Dudley, Samuel C.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Activation of the unfolded protein response downregulates cardiac ion channels in human induced pluripotent stem cell-derived cardiomyocytes</atitle><jtitle>Journal of molecular and cellular cardiology</jtitle><addtitle>J Mol Cell Cardiol</addtitle><date>2018-04-01</date><risdate>2018</risdate><volume>117</volume><spage>62</spage><epage>71</epage><pages>62-71</pages><issn>0022-2828</issn><eissn>1095-8584</eissn><abstract>Heart failure is characterized by electrical remodeling that contributes to arrhythmic risk. The unfolded protein response (UPR) is active in heart failure and can decrease protein levels by increasing mRNA decay, accelerating protein degradation, and inhibiting protein translation.
Therefore, we investigated whether the UPR downregulated cardiac ion channels that may contribute to arrhythmogenic electrical remodeling.
Human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) were used to study cardiac ion channels. Action potentials (APs) and ion channel currents were measured by patch clamp recording. The mRNA and protein levels of channels and the UPR effectors were determined by quantitative RT-PCR and Western blotting. Tunicamycin (TM, 50 ng/mL and 5 μg/mL), GSK2606414 (GSK, 300 nmol/L), and 4μ8C (5 μmol/L) were utilized to activate the UPR, inhibit protein kinase-like ER kinase (PERK) and inositol-requiring protein-1 (IRE1), respectively.
TM-induced activation of the UPR caused significant prolongation of the AP duration (APD) and a reduction of the maximum upstroke velocity (dV/dtmax) of the AP phase 0 in both acute (20–24 h) and chronic treatment (6 days). These changes were explained by reductions in the sodium, L-type calcium, the transient outward and rapidly/slowly activating delayed rectifier potassium currents. Nav1.5, Cav1.2, Kv4.3, and KvLQT1 channels showed concomitant reductions in mRNA and protein levels under activated UPR. Inhibition of PERK or IRE1 shortened the APD and reinstated dV/dtmax. The PERK branch regulated Nav1.5, Kv4.3, hERG, and KvLQT1. The IRE1 branch regulated Nav1.5, hERG, KvLQT1, and Cav1.2.
Activated UPR downregulates all major cardiac ion currents and results in electrical remodeling in hiPSC-CMs. Both PERK and IRE1 branches downregulate Nav1.5, hERG, and KvLQT1. The PERK branch specifically downregulates Kv4.3, while the IRE1 branch downregulates Cav1.2. Therefore, the UPR contributed to electrical remodeling, and targeting the UPR might be anti-arrhythmic.
•The unfolded protein response mediates arrhythmic electrical remodeling•Activated unfolded protein response downregulates all major cardiac ion currents•Electrical remodeling results in action potential prolongation•Electrical remodeling can be attenuated by inhibiting the unfolded protein response</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>29474817</pmid><doi>10.1016/j.yjmcc.2018.02.011</doi><tpages>10</tpages><orcidid>https://orcid.org/0000-0001-5843-5961</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0022-2828 |
ispartof | Journal of molecular and cellular cardiology, 2018-04, Vol.117, p.62-71 |
issn | 0022-2828 1095-8584 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5861016 |
source | MEDLINE; Elsevier ScienceDirect Journals Complete |
subjects | Action Potentials - drug effects Adenine - analogs & derivatives Adenine - pharmacology Down-Regulation - drug effects eIF-2 Kinase - metabolism Endoribonucleases - metabolism Heart failure hiPSC-derived cardiomyocytes Humans Indoles - pharmacology Induced Pluripotent Stem Cells - cytology Ion Channel Gating - drug effects Ion Channels - metabolism IRE1 Isoproterenol - pharmacology Myocytes, Cardiac - drug effects Myocytes, Cardiac - metabolism PERK Protein-Serine-Threonine Kinases - metabolism Tunicamycin - pharmacology Unfolded Protein Response - drug effects Ventricular Remodeling - drug effects |
title | Activation of the unfolded protein response downregulates cardiac ion channels in human induced pluripotent stem cell-derived cardiomyocytes |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-10T18%3A04%3A09IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Activation%20of%20the%20unfolded%20protein%20response%20downregulates%20cardiac%20ion%20channels%20in%20human%20induced%20pluripotent%20stem%20cell-derived%20cardiomyocytes&rft.jtitle=Journal%20of%20molecular%20and%20cellular%20cardiology&rft.au=Liu,%20Man&rft.date=2018-04-01&rft.volume=117&rft.spage=62&rft.epage=71&rft.pages=62-71&rft.issn=0022-2828&rft.eissn=1095-8584&rft_id=info:doi/10.1016/j.yjmcc.2018.02.011&rft_dat=%3Cproquest_pubme%3E2007987379%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2007987379&rft_id=info:pmid/29474817&rft_els_id=S0022282818300452&rfr_iscdi=true |